港股異動丨耀才證券升超19%再創歷史新高,5日累升177%,獲螞蟻財富28億溢價收購
近日表現活躍的耀才證券金融(1428.HK)今日再度走高,盤中一度升超19%至8.45港元,再創歷史新高,市值超143億港元。4月25日復牌至今的5個交易日,該股累升177%。4月25日,耀才證券公吿稱,螞蟻集團通過旗下一家全資控股的境外主體,以每股3.28港元的價格向香港老牌券商耀才證券發起要約收購,總代價28.14億港元,目標直指其50.55%控股權。這一收購價格較其停牌前收盤價(4月23日)溢價7.5%,較2025年中期財報披露的每股淨資產(BPS)溢價365%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.